not tagged
not tagged
['rectal']
trials are showing much better response rates (up to 100%) in neoadjuvant rectal cancer than in the metastatic setting. this slide suggests why. #esmo22 
Consultant Oncology Pharmacist, Airedale NHSFT. Honorary Lecturer @BradfordUni. @BOPA Fellow. Very amateur gardener and brewer.